Laboratory for Cell and Gene Medicine
We Are Working to Cure the Incurable
Our mission is to develop innovative manufacturing platforms for the GMP manufacture of cell and gene therapy products enabling Stanford investigators to bridge the “bench to bedside” gap for treating patients with large unmet medical needs. Our state-of-the-art cGMP facility and highly skilled professionals provide support and services to Stanford Medicine centers and industry partners.
Featured News story
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
The California Institute for Regenerative Medicine (CIRM) awarded Stanford University $2,000,000 as part of their $10,000,000 Phase One Initiative to build a California Cell and Gene Therapy Manufacturing Network. Steven Feldman, PhD, was the recipient of this award with his work in Stanford's LCGM and his INFR5-14663 application. The full program title is the "Laboratory for Cell and Gene Medicine: A Partner in the California Cell and Gene Therapy Manufacturing Network".
